Verastem | VSTM - Pre Tax Profit


Verastem reported $-36.59M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Alaunos Therapeutics USD -7.84M 633K Dec/2023
AstraZeneca USD 4.81B 894M Jun/2026
Curis USD -24.2M 43.56M Mar/2026
Cytokinetics USD -206.03M 23M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
Incyte USD 751.51M 407.91M Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Novartis USD 4.27B 430M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
TG Therapeutics USD 10.23M 10.13M Jun/2026
Verastem USD -36.59M 3.68M Mar/2026